CareDx Inc. | Mutual Funds
Mutual Funds that own CareDx Inc.
Alger Growth Opportunities Fund
1,346,282
3.7%
1,346,282
3.47%
01/31/2018
Legg Mason Global Funds Plc - Royce US Small Cap Opportunity
697,116
1.92%
-87,940
1.25%
06/30/2018
iShares Russell 2000 ETF
676,944
1.86%
-363
0.03%
09/06/2018
Vanguard Total Stock Market Index Fund
675,488
1.86%
0
0%
07/31/2018
PowerShares DWA Small Cap Momentum Portfolio
438,810
1.21%
0
2.35%
09/05/2018
Emerald Growth Fund
437,450
1.2%
437,450
0.75%
04/30/2018
Vanguard Extended Market Index Fund
426,550
1.17%
0
0.01%
07/31/2018
Baron Discovery Fund
405,000
1.11%
405,000
3.07%
06/30/2018
iShares Russell 2000 Growth ETF
297,326
0.82%
0
0.06%
09/06/2018
PowerShares DWA Healthcare Momentum Portfolio
260,751
0.72%
12,417
2.06%
09/05/2018
| Address |
3260 Bayshore Boulevard
Brisbane California 94005
United States
|
|
Employees
|
- |
| Website |
http://www.caredxinc.com |
| Updated |
07/08/2019 |
| CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test. |
